Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/13449
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Shen, Pei-Juan | en |
dc.contributor.author | Gundlach, Andrew L | en |
dc.date.accessioned | 2015-05-16T03:18:05Z | |
dc.date.available | 2015-05-16T03:18:05Z | |
dc.date.issued | 1996-05-01 | en |
dc.identifier.citation | The European Journal of Neuroscience; 8(5): 988-1000 | en |
dc.identifier.govdoc | 8743747 | en |
dc.identifier.other | PUBMED | en |
dc.identifier.uri | http://ahro.austin.org.au/austinjspui/handle/1/13449 | en |
dc.description.abstract | Chromogranin/secretogranins are a family of acidic, soluble proteins with a widespread distribution in secretory vesicles of endocrine and nervous tissues. The effects of experimental stimuli of differing duration and intensity on chromogranin B and secretogranin II mRNA levels in relevant areas of the rat brain were examined by in situ hybridization histochemistry using 35S-labelled oligonucleotides. Effects of two 'chronic stimulation' paradigms were studied - the effect of 4 days of water or food deprivation on mRNA levels in the hypothalamus and the effect of unilateral cervical vagotomy on transcript levels in the dorsal vagal complex 1, 2 and 7 days after surgery. After 4 days of water deprivation secretogranin II mRNA was significantly increased in supraoptic nucleus (366 +/- 21% of control, P < 0.01), the magnocellular paraventricular nucleus (209 +/- 20% of control, P < 0.01) and the parvocellular paraventricular nucleus (147 +/- 6% of control, P < 0. 05) after 4 days of food deprivation. Seven days after unilateral cervical vagotomy, secretogranin II and chromogranin B mRNA levels were markedly decreased in the ipsilateral dorsal motor nucleus of the vagus (25 +/- 4 and 47 +/- 8% of contralateral values respectively, P < 0.01). Rapid changes in chromogranin mRNA were also detected following shorter duration 'acute stimulation' - in the hypothalamus after hypertonic saline injection, in the hippocampus after electrical stimulation-induced kindled seizures, and in the cerebral cortex after unilateral craniotomy. A large increase in secretogranin II mRNA was detected in the supraoptic nucleus (202 +/- 25% of control, P < 0.01) and the magnocellular paraventricular nucleus (168 +/- 29% of control, P < 0.05) 3 h after a single intraperitoneal injection of hypertonic (1.8 M) saline. Markedly increased levels of secretogranin II (125-160% of control) and chromogranin B (140-230% of control) mRNA were observed in granule cells of the dentate gyrus 0.5-2 h after amygdaloid stimulation-induced seizures. A moderate increase in secretogranin II mRNA (144 +/- 11% of contralateral side, P < 0.01) was found in the underlying cerebral cortex 2.5 h after unilateral craniotomy. These results indicate that measurement of changes in chromogranin mRNA, particularly secretogranin II, is a useful means of assessing both rapid and long-lasting increases and decreases in neuronal activity and, in contrast to immediate early gene mRNA levels, may better reflect specific changes in neuronal secretory activity associated with transmitter/peptide release. | en |
dc.language.iso | en | en |
dc.subject.other | Animals | en |
dc.subject.other | Axons.physiology | en |
dc.subject.other | Base Sequence | en |
dc.subject.other | Brain.cytology.metabolism | en |
dc.subject.other | Chromogranins.genetics | en |
dc.subject.other | Genetic Markers | en |
dc.subject.other | Male | en |
dc.subject.other | Molecular Sequence Data | en |
dc.subject.other | Nerve Tissue Proteins.genetics | en |
dc.subject.other | Neurons.metabolism | en |
dc.subject.other | Osmotic Pressure | en |
dc.subject.other | Proteins.genetics | en |
dc.subject.other | RNA, Messenger.metabolism | en |
dc.subject.other | Rats | en |
dc.subject.other | Rats, Sprague-Dawley | en |
dc.subject.other | Seizures.metabolism | en |
dc.subject.other | Time Factors | en |
dc.subject.other | Water Deprivation.physiology | en |
dc.title | Chromogranin mRNA levels in the brain as a marker for acute and chronic changes in neuronal activity: effect of treatments including seizures, osmotic stimulation and axotomy in the rat. | en |
dc.type | Journal Article | en |
dc.identifier.journaltitle | The European journal of neuroscience | en |
dc.identifier.affiliation | University of Melbourne, Clinical Pharmacology and Therapeutics Unit, Department of Medicine, Austin and Repatriation Medical Centre, Heidelberg, Victoria 3084, Australia | en |
dc.description.pages | 988-1000 | en |
dc.relation.url | https://pubmed.ncbi.nlm.nih.gov/8743747 | en |
dc.type.austin | Journal Article | en |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.fulltext | No Fulltext | - |
item.cerifentitytype | Publications | - |
item.grantfulltext | none | - |
item.languageiso639-1 | en | - |
item.openairetype | Journal Article | - |
Appears in Collections: | Journal articles |
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.